Screener
Prime Medicine PRME Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue — related party | 7,934 | 7,824 |
| Operating lease liability | 8,972 | 8,137 |
| Total current liabilities | 31,692 | 37,448 |
| Deferred revenue, net of current — related party | 56,033 | 58,127 |
| Operating lease liability, net of current | 103,506 | 108,290 |
| Research and development funding liability | 18,000 | 18,000 |
| Total liabilities | 209,231 | 221,865 |
| Commitments and contingencies |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's contract liabilities, non-current?
- Prime Medicine (PRME) reported contract liabilities, non-current of $56.03M in Q2 2026.
- How has Prime Medicine's contract liabilities, non-current changed year-over-year?
- Prime Medicine's contract liabilities, non-current decreased by 5.9% year-over-year, from $59.56M to $56.03M.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about Prime Medicine's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude